title: Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure.
abstract: Long-acting natriuretic peptide, vessel dilator, and atrial natriuretic factor consisting of amino acids (a.a.) 1 to 30, 31 to 67, and 99 to 126 of the 126-a.a. atrial natriuretic factor (ANF) prohormone, respectively, circulate in humans and have potent vasodilatory properties. To determine if these atrial natriuretic peptides are directly related to blood pressure in clinically healthy normotensive humans, we obtained 24-h profiles of vessel dilator, long-acting natriuretic peptide, ANF, and blood pressure in 10 men in 1988 and 11 men in 1993 (seven men were studied twice) to compare circulating concentrations of atrial natriuretic peptides with naturally occurring changes in blood pressure. Overall, vessel dilator, long-acting natriuretic peptide, and ANF each had significant (p<0.001) circadian rhythms, with peak concentrations late during sleep (at 04:00 h) being nearly twice their concentrations in the afternoon and evening. This high-amplitude circadian change allowed for the refinement of normal limits for ANF peptides by computing 3-hourly tolerance intervals (chronodesms) against which to compare time-specified single samples for normality. Systolic, diastolic, and mean arterial blood pressure also had significant circadian rhythms (p<0.001) with peaks and troughs that were exactly opposite those of the ANF peptides. In addition to this inverse temporal relationship, there was a significant inverse correlation between absolute values for blood pressure and each ANF peptide (p<0.001), implying a functional relationship. These data suggest that in addition to other well-established neurochemical factors, the ANF peptides (vessel dilator, long-acting natriuretic peptide, and ANF) are important for the maintenance of blood pressure and modulation of its circadian rhythm.
authors.affiliation: Rhythmometry Laboratory, St. Paul-Ramsey Medical Center, Minneapolis, Minnesota, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Sothern
authors.forename: D L
authors.initials: DL
authors.lastname: Vesely
authors.forename: E L
authors.initials: EL
authors.lastname: Kanabrocki
authors.forename: R C
authors.initials: RC
authors.lastname: Hermida
authors.forename: F W
authors.initials: FW
authors.lastname: Bremner
authors.forename: J L
authors.initials: JL
authors.lastname: Third
authors.forename: M A
authors.initials: MA
authors.lastname: Boles
authors.forename: B M
authors.initials: BM
authors.lastname: Nemchausky
authors.forename: J H
authors.initials: JH
authors.lastname: Olwin
authors.forename: L E
authors.initials: LE
authors.lastname: Scheving
mesh_terms: D000328:Adult; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000096:biosynthesis / Q000097:blood* / Q000302:isolation & purification; D001794:Blood Pressure; D001808:Blood Vessels / Q000502:physiology; D002940:Circadian Rhythm; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D008955:Models, Cardiovascular; D010446:Peptide Fragments / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D011863:Radioimmunoassay; D012044:Regression Analysis; D014664:Vasodilation
chemical_list: D010446:Peptide Fragments; D011498:Protein Precursors; C054547:atrial natriuretic factor prohormone (1-30), human; C054548:atrial natriuretic factor prohormone (31-67); D009320:Atrial Natriuretic Factor